Conavi Medical Statistics
Total Valuation
Conavi Medical has a market cap or net worth of 26.01 million. The enterprise value is 36.16 million.
| Market Cap | 26.01M |
| Enterprise Value | 36.16M |
Important Dates
The last earnings date was Friday, December 19, 2025.
| Earnings Date | Dec 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 76.75M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +833.52% |
| Shares Change (QoQ) | +12.63% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 0.00% |
| Float | 42.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.97 |
| PB Ratio | -2.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.45 |
| EV / Sales | 5.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.00 |
Financial Position
The company has a current ratio of 1.01
| Current Ratio | 1.01 |
| Quick Ratio | 0.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.79 |
| Interest Coverage | -1.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -88.39% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -350.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.87 |
| Inventory Turnover | 1.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.95% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -29.95% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.37 |
| Relative Strength Index (RSI) | 48.14 |
| Average Volume (20 Days) | 27,299 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Conavi Medical had revenue of 6.55 million and -14.73 million in losses. Loss per share was -0.26.
| Revenue | 6.55M |
| Gross Profit | 5.48M |
| Operating Income | -10.66M |
| Pretax Income | -14.73M |
| Net Income | -14.73M |
| EBITDA | -10.31M |
| EBIT | -10.66M |
| Loss Per Share | -0.26 |
Balance Sheet
The company has 4.19 million in cash and 14.29 million in debt, with a net cash position of -10.10 million.
| Cash & Cash Equivalents | 4.19M |
| Total Debt | 14.29M |
| Net Cash | -10.10M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -12.94M |
| Book Value Per Share | -0.17 |
| Working Capital | 41,640 |
Cash Flow
In the last 12 months, operating cash flow was -18.02 million and capital expenditures -52,409, giving a free cash flow of -18.07 million.
| Operating Cash Flow | -18.02M |
| Capital Expenditures | -52,409 |
| Free Cash Flow | -18.07M |
| FCF Per Share | n/a |
Margins
Gross margin is 83.61%, with operating and profit margins of -162.82% and -224.91%.
| Gross Margin | 83.61% |
| Operating Margin | -162.82% |
| Pretax Margin | -224.91% |
| Profit Margin | -224.91% |
| EBITDA Margin | -157.49% |
| EBIT Margin | -162.82% |
| FCF Margin | n/a |
Dividends & Yields
Conavi Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -833.52% |
| Shareholder Yield | -833.52% |
| Earnings Yield | -56.62% |
| FCF Yield | -69.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Conavi Medical has an Altman Z-Score of -21.33 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -21.33 |
| Piotroski F-Score | 4 |